Depression and fatigue during chronic IFN-&#945; administration were associated with alterations in the expression (OAS2) and transcriptional control (CREB/ATF) of genes linked to behavioral disorders including CFS and major depression, further supporting an immune contribution to these diseases.
C1269683
Major Depressive Disorder